ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
HU
Hospital Universitario Puerta de Hierro Majadahonda at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hospital Universitario Puerta de Hierro Majadahonda takes part in 18 sessions at ESMO 2026 in Madrid. Its program spans lung, ovarian, breast, and cervical cancers, alongside care access and patient wellbeing. Topics include treatment options for advanced lung cancer and exercise and heart-risk management after early breast cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
HU Hospital Universitario Puerta de Hierro Majadahonda Majadahonda, Spain | |
Public university hospital of the Madrid regional health service in Majadahonda, Spain, and a teaching hospital of the Autonomous University of Madrid. | Satellite Fri Oct 23 09:45–11:15 AbbVie - Riding the Wave of Innovation Towards Personalized Medicine in Ovarian Cancer Gynaecological cancers Satellite Fri Oct 23 09:45–11:15 Satellite Fri Oct 23 09:45–10:00 New Currents, New Directions: The Evolving Ovarian Cancer Treatment Paradigm Gynaecological cancers Satellite Fri Oct 23 09:45–09:50 Welcome and Introductions Lung & thoracic cancers Satellite Fri Oct 23 09:50–10:10 Exploring the Many Faces of NSCLC Management Lung & thoracic cancers Satellite Fri Oct 23 10:50–11:10 Keeping the Patient in the Center Lung & thoracic cancers Poster Fri Oct 23 13:00–15:00 A scoping review of shared decision-making in patients with advanced colorectal cancer Gastrointestinal cancersNursing & supportive care Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Chair Fri Oct 23 16:15–17:30 Optimising use of local therapy in advanced lung cancer: Why, when, and how Lung & thoracic cancers Talk Fri Oct 23 16:20–16:40 Medical oncology perspective Lung & thoracic cancers Abstract Sat Oct 24 09:19–09:24 Poster Sat Oct 24 12:00–12:45 Beyond quality of life: The CORE randomized trial of supervised exercise and cardiovascular risk control in early-stage breast cancer survivorship Breast cancerNursing & supportive care Satellite Sat Oct 24 13:00–14:30 GSK - From Discovery to Impact: ADCs in Endometrial and Ovarian Cancer Care Gynaecological cancers Satellite Sat Oct 24 13:00–13:15 The Evolving Landscape in Endometrial and Ovarian Cancers Gynaecological cancers Satellite Sat Oct 24 13:15–13:20 Audience polling Gynaecological cancers Talk Sun Oct 25 10:30–10:45 Financial toxicity and equity (access to treatment) Nursing & supportive care Poster Sun Oct 25 12:00–12:45 Impact of residential radon exposure on the molecular profile of lung cancer in Spain: Results from the RTT-ATLAS-Radon study Lung & thoracic cancersBiomarkers & precision oncology Satellite Sun Oct 25 13:00–14:30 Satellite Sun Oct 25 13:00–13:05 Welcome and Introductions Lung & thoracic cancers Satellite Sun Oct 25 13:05–13:20 What We Know and Don’t Know About Immunotherapy in Resectable NSCLC Lung & thoracic cancers Satellite Sun Oct 25 13:20–14:05 Neoadjuvant vs Perioperative Immunotherapy: An Expert Clinical Debate Lung & thoracic cancers Satellite Sun Oct 25 14:25–14:30 Close Lung & thoracic cancers Chair Sun Oct 25 14:45–16:15 Cervical cancer: From prevention to optimal therapy Gynaecological cancers Talk Sun Oct 25 15:25–15:45 Optimal systemic therapy for persistent, recurrent or metastatic disease Gynaecological cancers Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Patterns and outcomes of relapse in DLBCL: Real-world data from the national GOTEL registry Haematological malignancies |
Find decision makers at Hospital Universitario Puerta de Hierro Majadahonda
Tell us what you sell and we’ll find the people at Hospital Universitario Puerta de Hierro Majadahonda most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction